Antithrombotic efficacy of the vitamin K antagonist fluindione in a human ex vivo model of arterial thrombosis - Effect of anticoagulation level and combination therapy with aspirin

被引:14
作者
Bossavy, JP
Sakariassen, KS
Thalamas, C
Boneu, B
Cadroy, Y
机构
[1] CHU Purpan, Lab Rech Hemostase & Thrombose, F-31059 Toulouse, France
[2] CHU Purpan, Serv Chirurg Gen & Vasc, Toulouse, France
[3] Univ Oslo, Div Physiol, Dept Biol, Oslo, Norway
[4] CHU Purpan, Ctr Invest Clin, Toulouse, France
关键词
thrombosis; aspirin; anticoagulants;
D O I
10.1161/01.ATV.19.9.2269
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombin is a main mediator of arterial thrombus formation, and its inhibition is an important antithrombotic strategy. However, the place of vitamin K antagonists among the different therapeutic strategies for preventing arterial thrombus formation is still debated. We studied the antithrombotic efficacy of the vitamin K antagonist fluindione in a human ex vivo model of arterial thrombosis and determined whether aspirin enhances fluindione efficacy. Ten healthy male volunteers were randomly assigned to receive fluindione, alone or in combination with aspirin (325 mg/d). Fluindione was given at increasing doses to give a stable international normalized ratio (INR) between 1.5 and 2.0 and between 2.1 and 3.0, We induced arterial thrombus formation ex vivo by exposing collagen- or tissue factor (TF)-coated coverslips in a parallel-plate perfusion chamber to native blood for 3 minutes at an arterial wall shear rate of 2600 s(-1) Platelet and fibrin deposition were measured by immunoenzymatic methods. Fluindione inhibited thrombus formation on TF-coated coverslips in a dose-dependent manner by 50% and 80% at INR 1.5 to 2.0 and INR 2.1 to 3.0, respectively (P<0.05), Fluindione in combination with aspirin inhibited TF-induced thrombus formation in a comparable manner. Collagen-induced thrombus formation was not reduced in subjects treated by fluindione. It was reduced by 50% to 50% in those treated with fluindione plus aspirin, regardless of the level of anticoagulation (P<0.05). Thus, the effectiveness of fluindione for preventing arterial thrombosis is dependent on the nature of the thrombogenic trigger. Fluindione is very effective in preventing TF- but not collagen-triggered thrombus formation. Aspirin enhances the antithrombotic effectiveness of fluindione, because combined treatment interrupts both TF- and collagen-induced thrombus formation.
引用
收藏
页码:2269 / 2275
页数:7
相关论文
共 36 条
[1]  
ALTMAN R, 1976, J THORAC CARDIOV SUR, V72, P127
[2]  
BAUMGARTNER HR, 1976, PLATELETS BIOL PATHO, P23
[3]   A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans [J].
Bossavy, JP ;
Thalamas, C ;
Sagnard, L ;
Barret, A ;
Sakariassen, K ;
Boneu, B ;
Cadroy, Y .
BLOOD, 1998, 92 (05) :1518-1525
[4]   Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis [J].
Bossavy, JP ;
Sakariassen, KS ;
Rübsamen, K ;
Thalamas, C ;
Boneu, B ;
Cadroy, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (05) :1348-1353
[5]   A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis [J].
Bossavy, JP ;
Sakariassen, KS ;
Barret, A ;
Boneu, B ;
Cadroy, Y .
THROMBOSIS AND HAEMOSTASIS, 1998, 79 (01) :162-168
[6]  
CADROY Y, 1993, THROMB HAEMOSTASIS, V70, P631
[7]   DERMATAN SULFATE INHIBITION OF FIBRIN-RICH THROMBUS FORMATION IN NONHUMAN-PRIMATES [J].
CADROY, Y ;
HANSON, SR ;
HARKER, LA .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (08) :1213-1217
[8]   COMBINATION ANTITHROMBOTIC THERAPY IN UNSTABLE REST ANGINA AND NON-Q-WAVE INFARCTION IN NONPRIOR ASPIRIN USERS - PRIMARY END-POINTS ANALYSIS FROM THE ATACS TRIAL [J].
COHEN, M ;
ADAMS, PC ;
PARRY, G ;
XIONG, J ;
CHAMBERLAIN, D ;
WIECZOREK, I ;
FOX, KAA ;
CHESEBRO, JH ;
STRAIN, J ;
KELLER, C ;
KELLY, A ;
LANCASTER, G ;
ALI, J ;
KRONMAL, R ;
FUSTER, V .
CIRCULATION, 1994, 89 (01) :81-88
[9]  
DIQUELOU A, 1994, BLOOD, V84, P2206
[10]  
Fuster V, 1997, LANCET, V350, P389